“Breaking down silos and fostering collaboration to help rare disease patients” – The World Orphan Drug Congress convenes top pharmaceutical and biotech companies, public and private funders, patient advocacy groups and many more. IRDiRC is delighted to confirm the participation of Dr. David Pearce at the WODC USA during the 3 congress days, in the […]
Read More
We are delighted to announce that IRDiRC Chair, Dr. David Pearce, will be speaking at the World Orphan Drug Congress USA this April, in Boston, MA, USA. The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory bodies, patient advocacy organizations, payers, and investors. The congress serves as a platform […]
Read More
Only 8 days to go until the World Orphan Drug Congress USA 2024 in Boston (MA, USA, date: April 23-25). The WODC USA presents a golden opportunity to showcase the impactful work we’re doing and explore how collaborative efforts are shaping the future of rare disease research. Reserve your spot at the globally defining event […]
Read More
Just less than a month until the World Orphan Drug Congress in Boston! We are delighted to announce that IRDiRC is a proud partner and exhibitor at the World Orphan Drug Congress USA, taking place on April 23-25, 2024 in Boston (MA, USA). Don’t miss out IRDiRC Chair, Dr. David Pearce’s presentation of the “International […]
Read More
As part of our commitment in advancing initiatives related to rare diseases, IRDiRC is a proud partner at the 2024 World Orphan Drug Congress USA. This will be a defining event for the rare disease and orphan drug space globally, bringing together top key opinion leaders from around the globe. The upcoming event will cover […]
Read More